Terminated NA INTERVENTIONAL 1-arm NCT00186745

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Tinzaparin for Treatment of Venous Thromboembolism in Renal Insufficiency: A Pilot Study

Sponsor: Heart and Stroke Foundation of Ontario

Conditions Pulmonary Embolism Venous Thrombosis

Interventions Tinzaparin

Updated 5 times since 2017 Last updated: Apr 18, 2016 Started: Mar 31, 2005 Primary completion: Nov 30, 2015 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding ceased

Other Pulmonary Embolism trials with similar outcome

NCT02596555 · Phase PHASE4 · Feb 2020

Browse all Pulmonary Embolism trials

A NA clinical study on Pulmonary Embolism and Venous Thrombosis, this trial is terminated or withdrawn. The trial is conducted by Heart and Stroke Foundation of Ontario and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heart and Stroke Foundation of Ontario
LEO Pharma
St. Joseph's Healthcare Hamilton

Data source: St. Joseph's Healthcare Hamilton

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, Canada